The Global ELISA Market to Showcases Growth at a Significant CAGR of ~6% by 2027 | DelveInsight
The ELISA market is expected to prosper due to factors such as the increasing prevalence of infectious diseases such as HIV, tuberculosis, malaria, and hepatitis B, among others, growing application of ELISA for drug abuse testing, and increasing focus on improving the accuracy, portability, affordability, and usability of ELISA for end users, all of which are expected to result in significant revenue growth in the ELISA market during the forecast period (2022–2027).
LAS VEGAS, April 6, 2023 /PRNewswire/ -- DelveInsight's ELISA Market Insights report provides the current and forecast market analysis, individual leading ELISA companies' market shares, challenges, ELISA market drivers, barriers, and trends, and key ELISA companies in the market.
Key Takeaways from the ELISA Market Report
- As per DelveInsight estimates, North America is anticipated to dominate the global ELISA market during the forecast period.
- Notable ELISA companies such as Abbott, F. Hoffmann-La Roche Ltd, Erba Mannheim, Synbiotik, Maccura Biotechnology Co., Ltd., Thermo Fisher Scientific, DiaSorin, PerkinElmer Inc., Diatron, Werfen, ALPCO, Agilent, InBios International Inc., Awareness Technology Inc., Elabscience Biotechnology Inc., J. Mitra & Co. Pvt. Ltd., Rayto Life and Analytical Sciences Co., Ltd., BD, Trivitron Healthcare, and several others are currently operating in the ELISA market.
- In February 2023, Charles River Laboratories International, Inc. announced the availability of its first Enzyme-Linked Immunosorbent Assay (ELISA) Kit for the detection and quantification of residual host cell proteins (HCP) in CHO-based biotherapeutics. The sensitivity and specificity of Charles River's HCP ELISA kit are industry-leading, reaching 0.1 ng/mL and 90% antibody coverage, respectively.
To read more about the latest highlights related to the ELISA market, get a snapshot of the key highlights entailed in the Global ELISA Market Report
ELISA Overview
Enzyme-linked immunosorbent assay, or ELISA is the standard assay technique used to identify and quantify antibodies, hormones, peptides, and proteins in the blood. Blood proteins known as antibodies are created in response to a particular antigen in the case of certain viral illnesses. The antigen is adsorbed on a solid surface during the biochemical reaction known as ELISA. When a substrate that is specific to the linked enzyme is added, an antibody that has been linked to an enzyme is identified. The ELISA test is utilized in pharmaceutical quality control tests like endotoxin assays and protein quantification and is crucial in the diagnosis of several viral diseases.
ELISA Market Insights
North America is expected to lead the global ELISA market in terms of revenue generation. This can be attributed to the presence of a large patient pool associated with infectious diseases, government support, high consumer awareness regarding new market launches, and a highly potent market in terms of product development and launches, among other factors in the region. The rising prevalence of infectious diseases such as malaria, tuberculosis, hepatitis B, and others is expected to propel the ELISA market forward. According to the Centers for Disease Control and Prevention 2022, approximately 8K new tuberculosis cases were reported in the United States in 2021. According to CDC 2022, nearly 2K malaria cases are reported annually in the United States. Furthermore, the region's increasing number of blood donations and transfusions necessitates using ELISA kits to detect hepatitis B and other infections to avoid the risk of transfusing infected blood into patients.
To know more about why North America is leading the market growth in the ELISA market, get a snapshot of the ELISA Market Outlook
The rise in cases of sexually transmitted diseases worldwide is one of the notable drivers of the ELISA market. Another driver for the ELISA market is the various cancer types that affect millions of people worldwide. The increasing use of ELISA in drug abuse testing is expected to increase demand, positively impacting ELISA market growth. Furthermore, continuous research and development across the pharmaceutical and biotechnology industries are driving growth in the ELISA market.
However, the availability of alternative products and ELISA limitations may constrain the ELISA market's growth.
Additionally, during the COVID-19 infection period, the ELISA market grew slightly due to an increase in the number of cases, which increased the demand for diagnostic tools and technologies. The COVID-19 pandemic resulted in many FDA approvals of ELISA-based diagnostic kits for emergency use, which led to the development of sensitive and reliable ELISA-based diagnostic kits for detecting Sars COV-2. As a result, the ELISA market will benefit. During the forecast period of 2022–2027, the pandemic scenario has been positive for the ELISA market.
Get a sneak peek at the ELISA market dynamics @ ELISA Market Dynamics Analysis
Report Metrics |
Details |
Coverage |
Global |
Study Period |
2019–2027 |
Base Year |
2021 |
ELISA Market CAGR |
~6% |
Projected ELISA Market Size by 2027 |
USD 7.58 Billion |
Key ELISA Companies |
Abbott, F. Hoffmann-La Roche Ltd, Erba Mannheim, Synbiotik, Maccura Biotechnology Co., Ltd., Thermo Fisher Scientific, DiaSorin, PerkinElmer Inc., Diatron, Werfen, ALPCO, Agilent, InBios International Inc., Awareness Technology Inc., Elabscience Biotechnology Inc., J. Mitra & Co. Pvt. Ltd., Rayto Life and Analytical Sciences Co.,Ltd., BD, Trivitron Healthcare, among others |
ELISA Market Assessment
- ELISA Market Segmentation
- Market Segmentation By Product Type: Kits And Reagents, Elisa Systems, and Others
- Market Segmentation By Application: HIV, Pregnancy Testing, COVID-19, and Others
- Market Segmentation By End User: Hospitals And Diagnostic Labs, Pharmaceutical And Biotech Industries, and Others
- Market Segmentation By Geography: North America, Europe, Asia-Pacific, and Rest of World
- Porter's Five Forces Analysis, Product Profiles, Case Studies, KOL's Views, Analyst's View
Which MedTech key players in the ELISA market are set to emerge as the trendsetter explore @ ELISA Companies
Table of Contents
1 |
Report Introduction |
2 |
Executive summary |
3 |
Regulatory and Patent Analysis |
4 |
Key Factors Analysis |
5 |
Porter's Five Forces Analysis |
6 |
COVID-19 Impact Analysis on ELISA Market |
7 |
ELISA Market Layout |
8 |
Global Company Share Analysis – Key 3-5 Companies |
9 |
ELISA Market Company and Product Profiles |
10 |
Project Approach |
11 |
About DelveInsight |
Interested in knowing the ELISA market by 2027? Click to get a snapshot of the ELISA Market Trends
Related Reports
Cancer Therapy Market Insight, Competitive Landscape, and Market Forecast – 2027 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key cancer therapy companies, including GlaxoSmithKline, Eli Lilly & Company, F. Hoffmann-La Roche Ltd, AbbVie Inc., Amgen Inc, Sanofi, among others.
Oncology Drugs Market Insight, Competitive Landscape, and Market Forecast – 2027 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key oncology drugs companies, including GlaxoSmithKline, Eli Lilly & Company, F. Hoffmann-La Roche Ltd, among others.
Cardiac Biomarkers Testing Market
Cardiac Biomarkers Testing Market Insight, Competitive Landscape, and Market Forecast – 2027 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key cardiac biomarkers testing companies, including Beckman Coulter, Inc, Siemens Healthcare GmbH, Abbott, among others.
Intratumoral Cancer Therapies Market
Intratumoral Cancer Therapies Market Insight, Epidemiology, and Market Forecast – 2032 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key intratumoral cancer therapies companies, including Daiichi Sankyo, Amgen, Idera Pharmaceuticals, among others.
Liquid Biopsy in Cancer Diagnostics Market
Liquid Biopsy in Cancer Diagnostics Market Insight, Competitive Landscape, and Market Forecast – 2027 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key liquid biopsy in cancer diagnostics companies, including Myriad Genetics Inc, Exact Sciences Corporation, Biocartis, Sysmex Corporation, among others.
Other Trending Reports
Tay-sachs Disease Or Gm2 Gangliosidosis Market | Onycholysis Market | Diagnostic Imaging Equipment Market | Chemotherapy-induced Peripheral Neuropathy Market | Global Electrophysiology Devices Market | Anaphylaxis Market | Atherectomy Devices Market | Helicobacter Pylori Infections Market | Ophthalmic Imaging Equipment Market | Androgenetic Alopecia Market | Allergic Rhinitis Market | Chronic Inflammatory Demyelinating Polyneuropathy Market | Chronic Inflammtory Demyelinating Polyneuropathy Market | Colorectal Cancer Crc Market | Opioid Induced Constipation Market | Vertigo Market | Bone Anchored Hearing Systems Market | Wound Closure Devices Market | Hip Replacement Devices Market | Hemodynamic Monitoring Systems Market | Egfr Non-small Cell Lung Cancer Market | Helicobacter Pylori Infection Market | Hyperkalemia Market | Polycythemia Market Neurostimulation Devices Market | Carpal Tunnel Syndrome Market | Ventilator Market | Cerebral Aneurysm Market | Alpha Antitrypsin Market | Binge Eating Disorder Market | Bunion Market | Concussions Market Size | Exocrine Pancreatic Insufficiency Market | Healthcare Due Diligence Services | Minimal Residual Disease Market | Hypertrophic Scar Market | Lung Fibrosis Market | Anterior Uveitis Market | 22q11.2 deletion syndrome Market | X-Linked Retinitis Pigmentosa (XLRP) Market | Acute Radiation Syndrome Market | Alpha-1 Protease Inhibitor Deficiency Market | Androgenetic Alopecia Market | Hyperlipidemia Market | Cardiotoxicity Market | Hypertrophic Cardiomyopathy Market | Fatty Acid Oxidation Disorders (FAODs) Market | Androgen Insensitivity Syndrome Market | Emphysema Market | Canaloplasty Market | Dravet Syndrome Market | Celiac Disease Market | Chlamydia Infections Market | Syphilis Market | Renal Tubular Acidosis Market | Palmoplantar Pustulosis (PPP) Market | Aplastic Anemia Market | Bacterial Pneumonia Market | B cell Chronic Lymphocytic Leukemia Market | B cell Lymphomas Market | Behcets Disease Market Neoantigen-based Personalized Cancer therapeutic Vaccines Competitive Landscape and Market Forecast—by 2035 | Glioblastoma Market
Related Healthcare Blogs
Upcoming Oncological Drugs in 2022
Metastatic Castration-Sensitive Prostate Cancer Treatment Market
Checkpoint Inhibitor Refractory Cancer Market
Promising Oncolytic Virues Candidates in Pipeline
ENHERTU's Journey in Cancer Treatment and Management
Potential of PD-1 and PD-L1 Inhibitors in Cancer Management
Evolving EGFR NSCLC Treatment Market Dynamics
Emerging Role of Digital Health in the Field of Oncology
Related Cases Studies
Related Healthcare Services
Healthcare Competitive Intelligence Services
Healthcare Asset Prioritization Services
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports pharma companies by providing comprehensive end-to-end solutions to improve their performance. Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve.
Connect with us on LinkedIn | Facebook | Twitter
Contact Us
Shruti Thakur
[email protected]
+1(919)321-6187
https://www.delveinsight.com/medical-devices
Logo: https://mma.prnewswire.com/media/1082265/DelveInsight_Logo.jpg
SOURCE DelveInsight Business Research, LLP
Share this article